Management of Cardiovascular Risk Factors

Completed

• Conditions: Cardiovascular Risk Factors; Cardiovascular Diseases

• Registration Number: NCT00848380
• Lead Sponsor: AstraZeneca

Brief Summary

This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02
• Study First Submitted: 2009-02-19
• Study First Submitted QC: 2009-02-19
• Study First Posted: 2009-02-20
• Primary Completion: 2009-12
• Study Completion: 2009-12
• Status Verified: 2010-11
• Last Update Submitted: 2010-11-15
• Last Update Posted: 2010-11-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1492

Inclusion Criteria

• Patients received a anti-hypertension treatment in addition to cholesterol lowering treatment during the observation period
• Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period
• Patients received during the observation time new cholesterol lowering and hypertension treatment

Exclusion Criteria

• Patients received during the observation time only cholesterol lowering or only anti-hypertension treatment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia.	Inclusion visit, 6 to 9 months before inclusion visit and / or 12 to 15 months before inclusion visit

Trial Locations

Locations (1)

Research Site; 🇨🇭 Zurich, ZH, Switzerland